Dr. Daniel Sparks

LYRX has been developed by Dr. Daniel Sparks. Dr. Sparks obtained a PhD in Medicine from the University of British Columbia, in the field of Cardiovascular Pathology. Dr. Sparks has published numerous papers over a 30-year career as a cardiovascular research scientist at the University of Ottawa Heart Institute. Dr. Sparks has significant drug development experience and this work led to numerous medicinal inventions and issued USPTO patents. This led to the founding of the biotechnology company, Liponex, with the goal to develop cardiovascular therapeutics from natural source compounds. The company successfully completed an IPO in 2005.